Focused ultrasound for ablation of the subthalamic nucleus in one hemisphere improved motor features in a selected group of patients with markedly asymmetric Parkinson's disease, but was associated with a high rate of adverse events, including dyskinesias and other neurologic complications, in a new randomized sham-controlled trial published online...

The first blood test to detect the presence of amyloid, a hallmark of Alzheimer's disease (AD), is now available for clinical use, the company behind the test's development, C2N Diagnostics, has announced. The availability of the noninvasive, easily administered test is being called a milestone in the early detection and diagnosis of AD.

Neutrophil granulocyte biomarkers can distinguish between neuromyelitis optica spectrum disorders (NMOSD) and anti-MOG antibody-associated disease (MOGAD) on one hand and multiple sclerosis (MS) on the other hand.

In a new article ( Murueta‐Goyena, A., Del Pino, R., Galdós, et al. (2020), Retinal thickness predicts the risk of cognitive decline in Parkinson's disease. Ann Neurol doi:10.1002/ana.25944) the researchers analyzed longitudinal changes of retinal thickness and their predictive value as biomarkers of disease progression in idiopathic Parkinson's...

A new study has added support to the idea that coffee consumption is associated with a reduced risk of developing Parkinson's disease and suggests that caffeine may be a particularly beneficial for individuals with a genetic mutation linked to the condition.

Atogepant is an orally administered, small-molecule, calcitonin gene-related peptide (CGRP) receptor antagonist under investigation for treatment of migraine.

Listening to Mozart's piano music improves epilepsy, according to a meta-analysis presented at the virtual congress of the European College of Neuropsychopharmacology.

In patients with pediatric-onset multiple sclerosis (MS), increased abundance of Blautia stercoris and its variants in the gut is associated with an increased risk of relapse.